ACET logo

Adicet Bio (ACET)

Profile

Full Name

Adicet Bio, Inc.

Ticker Symbol

ACET

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 26, 2018

Indexes

Not included

Website

http://www.adicetbio.com

Employees

152

Key Details

Price

$0.57(-3.50%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.33(+59.82% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.57
ACET price is $0.57

30-Day Relative Volume

0.50
ACET 30-day relative volume is 0.50

Price Performance

Price Today change

-3.5%
ACET price is down -3.5% today

Price YTD change

-40.61%
ACET price is down -40.61% since January 1st

Price 1-year change

-73.91%
ACET price is down -73.91% year-on-year

Price 3-year change

-96.62%
ACET price is down -96.62% over the past 3 years

Price Range

Price All-time high

$147.68
ACET price is currently -99.61% below its historical high of $147.68

Price 3-year low

$0.45
ACET price is currently +27.81% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$47.24M
ACET market capitalization is $47.24 million

Market cap 3-year change

-93.02%
ACET market capitalization is down -93.02% over the past 3 years

Market cap All-time high

$911.45M
ACET market capitalization is currently -94.82% below its historical high of $911.45 million

Market cap sector rank

37.34%
ACET market capitalization is higher than 37.34% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.63%
ACET shares outstanding is up +0.63% year-on-year

Shares Outstanding 3-Year Change

+106.69%
ACET shares outstanding is up +106.69% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.86
ACET beta is 0.86

200-day SMA

$1.13
ACET price is currently -49.42% below its 200-day simple moving average

50-day SMA

$0.81
ACET price is currently -29.24% below its 50-day simple moving average

RSI

37.77
ACET 14-day relative strength index is 37.77

Volume

0.50
ACET 30-day relative volume is 0.50

ATR

$0.07
ACET average true range is $0.07

10-day Historical Volatility

158.91%
ACET 10-day historical volatility is 158.91%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ACET annual revenue value is unknown

Revenue Analysts estimate

-
ACET annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
ACET annual revenue 1-year change is unknown

Revenue Sector rank

-
ACET annual revenue is unknown

EPS

EPS

-$1.33
ACET annual earnings per share is -$1.33

EPS Analysts estimate

-$1.25
ACET annual earnings per share is currently +5.98% higher than the consensus analysts' forecast

EPS 1-year change

+59.82%
ACET annual earnings per share is up +59.82% year-on-year

EPS Sector rank

48.8%
ACET annual earnings per share is higher than 48.8% of companies in Healthcare sector

Profit

Gross profit

-
ACET annual gross profit value is unknown

Gross margin

-
ACET annual gross profit margin value is unknown

Operating profit

-$127.61M
ACET annual operating income is -$127.61 million

Operating margin

-
ACET annual operating profit margin value is unknown

Net income

-$117.12M
ACET annual net profit is -$117.12 million

Net margin

-
ACET annual net profit margin value is unknown

Expenses

Total expenses

$127.61M
ACET annual total expenses is $127.61 million

Operating expenses

$127.61M
ACET annual total operating expenses is $127.61 million

Cost of goods sold

-
ACET annual cost of goods sold value is unknown

Selling, general & administrative expenses

$28.29M
ACET annual SGA is $28.29 million

Depreciation and amortization

$6.47M
ACET annual depreciation & amortization is $6.47 million

Interest expense

$4000.00
ACET annual interest expense is $4000.00

Income tax

$0.00
ACET annual income tax is $0.00

EBIT & EBITDA

EBIT

-$117.12M
ACET annual earnings before interest & taxes is -$117.12 million

EBITDA

-$110.65M
ACET annual EBITDA is -$110.65 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$220.22M
ACET annual total assets is $220.22 million

Non current assets

$40.08M
ACET annual long term assets is $40.08 million

Current assets

$180.14M
ACET annual total current assets is $180.14 million

Cash and cash equivalents

$56.49M
ACET annual cash & cash equivalents is $56.49 million

Accounts receivable

-
ACET annual accounts receivable value is unknown

Inventory

-
ACET annual inventory value is unknown

Liabilities

Total liabilities

$33.61M
ACET annual total liabilities is $33.61 million

Long term liabilities

$14.22M
ACET annual total long term liabilities is $14.22 million

Current liabilities

$19.39M
ACET annual total current liabilities is $19.39 million

Accounts payable

$4.83M
ACET annual accounts payable is $4.83 million

Debt

Total debt

$17.23M
ACET annual total debt is $17.23 million

Total debt 1-year change

-17.64%
ACET annual total debt is down -17.64% year-on-year

Long term debt

$14.10M
ACET annual long term debt is $14.10 million

Short term debt

$3.13M
ACET annual short term debt is $3.13 million

Equity & Capital

Shareholders equity

$186.61M
ACET annual stockholders equity is $186.61 million

Book value

$186.61M
ACET annual book value is $186.61 million

Retained earnings

-$497.89M
ACET annual retained earnings is -$497.89 million

Working capital

$160.74M
ACET annual working capital is $160.74 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$92.38M
ACET annual cash flow from operations is -$92.38 million

Cash from operations 1-year change

+1.43%
ACET annual cash flow from operations is up +1.43% year-on-year

Cash from investing

-$119.24M
ACET annual cash flow from investing activities is -$119.24 million

Cash from investing 1-year change

-2571.19%
ACET annual cash flow from investing activities is down -2571.19% year-on-year

Cash from financing

$111.31M
ACET annual cash flow from financing activities is $111.31 million

Cash from financing 1-year change

+47063.98%
ACET annual cash flow from financing activities is up +47063.98% year-on-year

CAPEX

CAPEX

-
ACET annual capital expenditures value is unknown

CAPEX 1-year change

-
ACET annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$93.50M
ACET annual free cash flow is -$93.50 million

Free cash flow 1-year change

+4.77%
ACET annual free cash flow is up +4.77% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ACET annual gross profit margin value is unknown

Operating margin

-
ACET annual operating profit margin value is unknown

Net margin

-
ACET annual net profit margin value is unknown

ROA & ROE

ROA

-53.18%
ACET annual return on assets is -53.18%

ROE

-62.76%
ACET annual return on equity is -62.76%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ACET price to earnings ratio value is unknown

PE ratio Sector rank

-
ACET price to earnings ratio is unknown

PB Ratio

PB ratio

0.25
ACET price to book ratio is 0.25

PB ratio Sector rank

21.4%
ACET price to book ratio is higher than 21.4% of companies in Healthcare sector

PS Ratio

PS ratio

-
ACET price to sales ratio value is unknown

PS ratio Sector rank

-
ACET price to sales ratio is unknown

Enterprise value

Enterprise value

$7.98M
ACET enterprise value is $7.98 million

Enterprise value Sector rank

22.66%
ACET enterprise value is higher than 22.66% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.07
ACET EV/EBITDA is -0.07

EV/EBITDA Sector rank

62.58%
ACET EV/EBITDA is higher than 62.58% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

9.29
ACET annual current ratio is 9.29

Quick ratio

-
ACET annual quick ratio value is unknown

Leverage

Debt to equity

0.09
ACET annual debt to equity ratio is 0.09

Interest coverage ratio

-29.28K
ACET annual interest coverage ratio is -29.28 thousand

Risk & Stability

Piotroski F-Score

-
ACET piotroski f-score value is unknown

Altman Z-Score

-
ACET altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 21, 25 Guggenheim
Buy
Mar 7, 25 HC Wainwright & Co.
Neutral
Mar 7, 25 Citizens Capital Markets
Market Perform
Feb 27, 25 HC Wainwright & Co.
Neutral
Feb 6, 25 JMP Securities
Market Perform
Feb 5, 25 HC Wainwright & Co.
Neutral
Dec 19, 24 HC Wainwright & Co.
Neutral
Nov 18, 24 HC Wainwright & Co.
Neutral
Aug 14, 24 HC Wainwright & Co.
Buy
Aug 14, 24 Canaccord Genuity
Buy

Institutional Ownership

Similar stocks

Citius Oncology (CTOR)
ATHE logo
Alterity Therapeutics Limited (ATHE)
ZOM logo
Zomedica (ZOM)
BYSI logo
BeyondSpring (BYSI)
STRO logo
Sutro Biopharma (STRO)
ONCY logo
Oncolytics Biotech (ONCY)
VTVT logo
vTv Therapeutics (VTVT)
CUE logo
Cue Biopharma (CUE)
ALVR logo
AlloVir (ALVR)
  • What is the ticker symbol for Adicet Bio?
  • Does Adicet Bio pay dividends?
  • What sector is Adicet Bio in?
  • What industry is Adicet Bio in?
  • What country is Adicet Bio based in?
  • When did Adicet Bio go public?
  • Is Adicet Bio in the S&P 500?
  • Is Adicet Bio in the NASDAQ 100?
  • Is Adicet Bio in the Dow Jones?
  • When was Adicet Bio's last earnings report?
  • When does Adicet Bio report earnings?
  • Should I buy Adicet Bio stock now?

What is the ticker symbol for Adicet Bio?

The ticker symbol for Adicet Bio is NASDAQ:ACET

Does Adicet Bio pay dividends?

No, Adicet Bio does not pay dividends

What sector is Adicet Bio in?

Adicet Bio is in the Healthcare sector

What industry is Adicet Bio in?

Adicet Bio is in the Biotechnology industry

What country is Adicet Bio based in?

Adicet Bio is headquartered in United States

When did Adicet Bio go public?

Adicet Bio's initial public offering (IPO) was on January 26, 2018

Is Adicet Bio in the S&P 500?

No, Adicet Bio is not included in the S&P 500 index

Is Adicet Bio in the NASDAQ 100?

No, Adicet Bio is not included in the NASDAQ 100 index

Is Adicet Bio in the Dow Jones?

No, Adicet Bio is not included in the Dow Jones index

When was Adicet Bio's last earnings report?

Adicet Bio's most recent earnings report was on Mar 6, 2025

When does Adicet Bio report earnings?

The next expected earnings date for Adicet Bio is May 14, 2025

Should I buy Adicet Bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page